The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kruglova L.S.

Moskovskiĭ nauchno-prakticheskiĭ Tsentr dermatovenerologii i kosmetologii Departamenta zdravookhraneniia, Moskva

The pathogenetic aspects of the treatment of confined scleroderma

Authors:

Kruglova L.S.

More about the authors

Read: 2143 times


To cite this article:

Kruglova LS. The pathogenetic aspects of the treatment of confined scleroderma. Russian Journal of Clinical Dermatology and Venereology. 2011;9(6):72‑78. (In Russ.)

Recommended articles:
Infe­ctious factors in atopic dermatitis, pharmaceutical possibilities (systematic lite­rature review). Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):7-15
Epidemiology of M. geni­talium infe­ction. What is known?. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):143-152
Bacterial vagi­nosis: modern views. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):261-268
Study of the role of inte­rleukin-1β in blood serum in patients with acne. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):421-424
Liver pathology in COVID-19. Russian Journal of Archive of Pathology. 2025;(1):53-59
Pathogenesis of fibrosis deve­lopment in ovarian endo­metriosis. Russian Journal of Archive of Pathology. 2025;(2):73-78
Portopulmonary hype­rtension. Journal of Respiratory Medi­cine. 2025;(2):39-44

References:

  1. et al. Klinicheskaya dermatovenerologiya. Rukovodstvo dlya vrachei. Pod red. Yu.K. Skripkina, Yu.S. Butova. M 2009; 2: 234-277.
  2. Guseva N.G. Sistemnaya sklerodermiya: klinika, diagnostika, lechenie. Ros zhurn kozhn i ven bol 2002; 4: 5-15.
  3. Batkaev E.A., Galyamova Yu.A. Sklerodermiya. Uchebnoe posobie. M 2002; 24.
  4. Butov Yu.S, Toguzov R.T. Nekotorye aspekty patogeneza, klinika i terapiya sklerodermii. Ros zhurn kozhn i ven bol 2002; 4: 15-19.
  5. Furst A. Scleroderma: a fascinating, troubling disease. Adv Pract Nurs J 2004; 4: 2.
  6. Bolotnaya L.A., Shakhova F.B., Serbina I.M. Novoe v patogeneze i terapii ogranichennoi sklerodermii. Vestn dermatol i venerol 2004; 2: 31-34.
  7. Weibel L., Laguda B., Atherton D., Harper J.I. Misdiagnosis and delay in referral of children with localized scleroderma. Arch Dermatol 2011; 147: 9: 1115-1116.
  8. Vladimirtsev V.A., Avdeeva Zh.I., Guseva N.G. i dr. Izuchenie kletochnogo immunnogo otveta na kollagen 1-go tipa u bol'nykh sistemnoi sklerodermiei. Vopr revmatol 1982; 1: 33-38.
  9. Suchkova T.N. Narushenie T-kletochnogo immuniteta u bol'nykh ochagovoi sklerodermiei. Vestn dermatol 1986; 2: 12-16.
  10. Korn J.H. Immunologic aspects of scleroderma. Curr Opur Rheumatol 1991; 3: 947-952.
  11. Khamaganova I.V. Kliniko-diagnosticheskoe znachenie pokazatelei obmena soedinitel'noi tkani, lipidov i immunnogo disbalansa u bol'nykh sklerodermiei: Avtoref. dis. ... kand. med. nauk. M 1987.
  12. Yutskovskii A.D., Dubnyak N.S., Fedorova E.B. Differentsial'no-diagnosticheskie i immunologicheskie aspekty blyashechnoi sklerodermii. Ros zhurn kozhn i ven bol 2002; 4: 49-51.
  13. Dovzhanskii S.I. Kliniko-immunologicheskie paralleli pri ogranichennoi i sistemnoi sklerodermii. Ros zhurn kozhn i ven bol 2002; 4: 26-29.
  14. Fleming J.N., Nash R.A., Mahoney W.M.Jr. et al. Is scleroderma a vasculopathy? Curr Rheumatol Rep 2009; 11: 2: 103-110.
  15. Yamamoto T. Scleroderma - pathophysiology. Eur J Dermatol 2009; 19: 1: 14-24.
  16. Fleming K.F., Wu J.J., Dyson S.W. et al. Unilateral multisegmental morphea. Br J Dermatol 2011; 6: 1365-2133.
  17. Berenbein B.A., Studnitsin A.A. Differentsial'naya diagnostika kozhnykh boleznei. M: Meditsina 1989; 672.
  18. Ivanov O.L. Kozhnye i venericheskie bolezni. Spravochnik. M: Meditsina 1997; 352.
  19. Pal'tsev M.A., Potekaev N.N., Kazantseva I.I. i dr. Kliniko-morfologicheskaya diagnostika zabolevanii kozhi. M 2005; 427.
  20. Charles S., Clements R., Furst D. Systemic sclerosis: hypothesis-driven treatment strategies. Lancet 2006; 367: 9523: 1683-1691.
  21. Volnukhin V.A. K voprosu o lekarstvennoi terapii ogranichennoi sklerodermii. Sbornik trudov yubileinoi nauchno-praktiches­koi konferentsii, posvyashchennoi 10-letiyu kafedry kozhnykh i venericheskikh boleznei pediatricheskogo fakul'teta RGMU i otdeleniya dermatoallergologii RDKB. M 2002; 24-26.
  22. Dvornikov A.S, Kruglova L.S., Skripkin Yu.K. Opyt primeneniya Longidazy metodom fotoforeza u patsientov s ogranichennoi sklerodermiei. Vestn dermatol i venerol 2007; 5: 57-59.
  23. Oh C.K., Lee J., Jang B.S. et al. Treatment of atrophies secondary to trilinear scleroderma en coup de sabre by autologous tissue cocktail injection. Dermatol Surg 2003; 29: 10: 1073-1075.
  24. Obermoser G., Pfausler B.E., Bbinder D.M., Sepp N.T. Scleroderma en coup de sabre with central nervous system and ophthalmologic involvement: treatment of ocular symptoms with interferon gamma. J Am Acad Dermatol 2003; 49: 3: 543-546.
  25. Masternak T.B., Sharova O.V., Ivanova A.S. i dr. Otchet doklinicheskikh issledovanii OOO "NPO Petrovaks Farm". M 2005.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.